From the treatment of breast cancer to the treatment of the woman with cancer: history of breast surgery and its prejudices
Keywords:
breast cancer history, breast surgery, mastectomy, breast-conserving therapy, sentinel node biopsyAbstract
Background and aim: The article offers a comprehensive analysis of the historical evolution in breast cancer treatment since ancient times, when various methodologies were practiced, ranging from deliberate abstention to brutal treatments such as cauterization or amputation.
Methods: The analysis was conducted through an extensive review of literature and of articles in databases such as Medline, Google Scholar, and PubMed.
Results: Following the technique described by Halsted in 1894, which involved an extremely invasive procedure, advancements in scientific knowledge gradually allowed for more advanced surgical techniques that are respectful of bodily integrity. As treatments have evolved, the focus has been on increasing overall and disease-free survival. The increased understanding of tumor characteristics, adoption of multidisciplinary approaches, and societal shifts towards health have led to a significant evolution in breast cancer diagnosis and treatment.
Conclusions: This transition from aggressive to more tailored therapies, including localized and systemic treatments, has improved survival rates and patient quality of life. Current research is exploring the possibility that future breast cancer therapies may even eliminate the need for breast and axillary surgeries, thus revolutionizing the therapeutic approach.
References
Retief FP, Cilliers L. Breast cancer in antiquity. S Afr Med J. 2011;101(8): 513-5. PMID: 21920120.
Cotlar AM, Dubose JJ, Rose DM. History of surgery for breast cancer: radical to the sublime. Curr Surg. 2003; 60(3): 329-337. doi: 10.1016/s0149-7944(02)00777-8.
Nunn JF. Ancient Egyptian Medicine. Trans Med Soc Lond. 1996;113:57-68. PMID: 10326089.
Mansfield CM. Early breast cancer. Its history and results of treatment. Exp Biol 1976; 5:1-129. PMID: 791661.
Squilace G. I mali di Dario e Atossa. Modalità di intervento, tecniche terapeutiche, modelli di riferimento di Democede di Crotone (nota ad Erodoto III 129-134,1). In: De Sensi Sestito G, editor. L'arte di Asclepio, l’Arte di Asclepio Medici e malattie in età antica. Società antiche. Soveria Mannelli: Rubbettino Editore; 2008. pp. 29-62.
Herodotus. The Histories III,133-134. Cambridge: Harvard University Press; 1920.
Hippocrates. Epidemics II. 1.7;v.101.
Retief FP, Cilliers L. Chirurgie in die Grieks-Romeinse era. Suid-Afrik tydskr nat.wet tegnol. 2006; 25: 82-92. doi: 10.4102/satnt.v25i2.149.
Cooper WA. The history of radical mastectomy. Ann Med Hist 1941; 36-54. PMID: 33943287.
Cato. De Agricultura CLVII, 2-5.
Celsus. De re medicina v.28.2,3,7.
Retief FP, Cilliers L. Tumours and cancers in Graeco-Roman times. S Afr Med J. 2001; 4: 344-8.
Galen. Ad Glauconem de methodo medendi. K XI. 138.
Aëtius of Amida. Tetrabiblon xvi Transl. J Scarborough. 43-49,51,57,61.
Yan SH. An early history of human breast cancer: West meets East. Chin J Cancer 2013; 32:475-7. doi: 10.5732/cjc.013.10097.
Zarshenas MM, Mohammadi-Bardbori A. A medieval description of metastatic breast cancer; from Avicenna's view point. The Breast 2017; 31: 20-1. doi 10.1016/j.breast.2016.10.019.
Donegan WL. Introduction to the history of breast cancer. In: Cancer of the Breast. Donegan W L, Spratt J S. editors. Cancer of the breast. Philadelphia: WB Saunders; 1995.
Hager K. The Illustrated History of Surgery. New York: Bell; 1988.
Lewison EF. The surgical treatment of breast cancer. An historical and collective review. Surgery1953; 904-53. PMID: 13113516.
Petit JL. Traité des maladies chirurgicales et des operations qui leur conviennent. New York: Nabu Press; 2011.
Rayter Z. History of breast cancer therapy. Rayter Z, Mansi J, editors. Medical Therapy of Breast Cancer. Cambridge: Cambridge University Press.
Greaves M. Cancer-the evolutionary legacy. Oxford: Oxford University Press; 2000.
Patey DH. A review of 146 cases of carcinoma of the breast operated on between 1930 and 1943. Br J Cancer 1967; 21(2): 260-9. doi: 10.1038/bjc.1967.28.
Osborne MP. William Stewart Halsted: his life and contributions to surgery. Lancet Oncol. 2007; 8(3): 256-65. doi: 10.1016/S1470-2045(07)70076-1.
Abdalla S, Ellis H. William Sampson Handley (1872-1962): champion of the permeation theory of dissemination of breast cancer. J Med Biogr. 2013;21(2):108-11. doi: 10.1258/jmb.2012.012008.
Halsted WS. I. The Results of Radical Operations for the Cure of Carcinoma of the Breast. Ann Surg. 1907; 46(1):1-19. doi: 10.1097/00000658-190707000-00001. PMID: 17861990.
Crile G Jr. The smaller the cancer, the bigger the operation? Rationale of small operations for small tumors and large operations for large tumors. JAMA. 1967; 199(10): 736-8. doi: 10.1001/jama.199.10.736.
Fisher B, Montague E, Redmond C, et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer: a first report of results from a prospective randomized clinical trial. Cancer 1977; 39: Suppl: 2827-39. doi: 10.1002/1097-0142(197706)39:6<2827::aid-cncr2820390671>3.0.co;2-i.
Fisher B, Fisher ER. Barrier function of lymph node to tumor cells and erythrocytes. I. Normal nodes. Cancer. 1967; 20(11):1907-13. doi: 10.1002/1097-0142(196711)20.
Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, Lavin PT. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg. 1996;131(3): 301-8. doi: 10.1001/archsurg.1996.01430150079015.
Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med. 1981; 305(1): 6-11. doi: 10.1056/NEJM198107023050102.
Fregatti P, Gipponi M, Depaoli F, Murelli F, Guenzi M, Bonzano E, Ceppi M, Friedman D. No Ink on Ductal Carcinoma In Situ: A Single Centre Experience. Anticancer Res. 2019; 39(1): 459-66. doi: 10.21873/anticanres.13134.
Greco M, Crippa F, Agresti R, et al. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management. J Natl Cancer Inst. 2001; 93(8): 630-5. doi: 10.1093/jnci/93.8.630.
Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival — a Bayesian meta-analysis. Ann Surg Oncol 1999; 6:109-16. doi: 10.1007/s10434-999-0109-1.
Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ. Technical details of intraoperative lymphatic mapping for early-stage melanoma. Arch Surg. 1992;127(4): 392-9. doi: 10.1001/archsurg.1992.01420040034005.
Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977; 39(2): 456-66. doi: 10.1002/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO;2-I.
Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994; 220(3): 391-8; discussion 398-401. doi: 10.1097/00000658-199409000-00015.
Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P,
Leitch AM, et al. Locoregional recurrence after sentinel lymph
node dissection with or without axillary dissection in patients
with sentinel lymph node metastases: the American College of 2975. Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010; 252(03): 426-32, discussion 432-3. doi: 10.1097/ SLA.0b013e3181f08f32.
Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg. 1997;2 26(3):2 71-6; discussion 276-8. doi: 10.1097/00000658-19970900.
Galimberti V, Cole BF, Zurrida S, et al. International Breast Cancer Study Group Trial 23-01 investigators. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013; 14(4): 297-305. doi: 10.1016/S1470-2045(13)70035-4.
Giuliano AE, Hunt KK, Ballman KV, et al. Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis: A Randomized Clinical Trial. JAMA.2011; 305(6): 569-75. doi:10.1001/jama.2011.90.
Tinterri C, Canavese G, Gatzemeier W, et al. Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment. Br J Surg. 2023; 110(9): 1143-52. doi: 10.1093/bjs/znad215.
Gentilini OD, Botteri E, Sangalli C, et al. Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the sound randomized clinical trial. JAMA Oncol. 2023; 9(11): 1557-64. doi:10.1001/jamaoncol.2023.3759.
Ciliberti R, Alfano L, Baldelli I, De Stefano F, Bonsignore A. Self-determination, healthcare treatment and minors in Italian clinical practice: ethical, psychological, juridical and medical-legal profiles. Acta Biomed 2018; 89(1): 34-40. doi: 10.23750/abm.v89i1.6368.
Gipponi M, Baldelli I, Atzori G, Fregatti P, Murelli F, Pesce M, Margarino C, Depaoli F, Friedman D. Tumescent Anesthesia in Skin- and Nipple-sparing Mastectomy: Results of a Prospective Clinical Study. Anticancer Res. 2017; 37(1): 349-52. doi: 10.21873/anticanres.11328.
Fregatti P, Gipponi M, Atzori G, et al. The Margins' Challenge: Risk Factors of Residual Disease After Breast Conserving Surgery in Early-stage Breast Cancer. In Vivo. 2022; 36(2): 814-20. doi: 10.21873/invivo.12768.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Francesca Depaoli, Rosagemma Ciliberti
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
